Corpus Intelligence IC Memo — HALE HOOLA HAMAKUA 2026-04-26 15:42 UTC
IC Memo — HALE HOOLA HAMAKUA
Investment Committee Memorandum | HI | 11 beds | Grade D | EBITDA uplift $1.5M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

HALE HOOLA HAMAKUA

CCN 121307 | HAWAII, HI | 11 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

HALE HOOLA HAMAKUA is a 11-bed community hospital in HAWAII, HI with $20.2M in net patient revenue and a -20.3% operating margin. The hospital serves a payer mix of 44.2% Medicare, 0.0% Medicaid, and 55.8% commercial.

Thesis: Turnaround. Our ML models identify $1.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -20.3% to -12.9% (+736bps).

Net Revenue HCRIS$20.2M
Current EBITDA COMPUTED$-4.1M
Operating Margin COMPUTED-20.3%
Occupancy HCRIS60.2%
Revenue / Bed COMPUTED$1.8M
Net-to-Gross HCRIS81.7%
Distress Probability MLnan%

2. Market Context & Competitive Position

26
HI Hospitals
-14.7%
State Median Margin
715
Comparable Hospitals

HI has 26 Medicare-certified hospitals with a median operating margin of -14.7%. The target's margin of -20.3% places it below the state median. Among 715 size-comparable peers (6-22 beds), the median margin is -9.0%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (6-22), prioritizing same-state peers. 715 hospitals in the comp set.

HospitalStateBedsRevenueMargin
HALE HOOLA HAMAKUA (Target)HI11$20.2M-20.3%
FRED HUTCHINSON CANCER CENTERWA20$1.17B-50.0%
WENATCHEE VALLEY HOSPITALWA11$277.5M-4.9%
PORTERVILLE DEVELOPMENTAL CENTCA17$193.6M-6.0%
NATIONAL JEWISH HEALTHCO13$150.4M-50.0%
NORTON SOUND REGIONAL HOSPITALAK18$148.7M-28.6%
TEXAS SPINE AND JOINT HOSPITALTX20$147.3M30.3%
GREAT FALLS CLINIC MEDICAL CENMT20$132.1M21.0%
MARSHFIELD MEDICAL CENTER-MINOWI19$129.6M-12.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.5M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$425K+210bp18mo
Cost to Collect4.5%2.5%$405K+200bp12mo
Denial Rate Reduction12.0%6.5%$401K+198bp12mo
A/R Days Reduction5200.0%3800.0%$246K+122bp9mo
Clean Claim Rate88.0%96.0%$13K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$425K
Cost to Collect
$405K
Denial Rate Reduction
$401K
A/R Days Reduction
$246K
Clean Claim Rate
$13K
Total EBITDA Uplift$1.5M
Current EBITDA$-4.1M
+ RCM Uplift+$1.5M
Pro Forma EBITDA$-2.6M
Current Margin-20.3%
Pro Forma Margin-12.9%
WC Released (1x)$776K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-6.3M$-12.2M0.00x-100.0%
Base (11x exit)10.0x11.0x$-6.3M$-15.5M0.00x-100.0%
Bull Case9.0x11.0x$-5.7M$-12.6M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-5.7M$-15.4M0.00x-100.0%
Bear Case11.0x10.0x$-7.0M$-17.6M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-7.0M$-21.6M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 715 hospitals with 6-22 beds
  • Same-state prioritization (n=6)
  • Comp margins: P25=-24.1% / P50=-9.0% / P75=1.7%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.